Non categorizzato Viking Therapeutics soars 22% on trial progress Luglio 25, 2024 0 commenti Viking Therapeutics surged over 22% on Thursday after the biotech company announced its weight loss injection, VK2735, will advance to a late-stage trial ahead of schedule.The development brings the S… About the author:
Get involved!
Comments